Should gatifloxacin be included in the model list of essential medicines?

Eur Respir J. 2018 Feb 7;51(2):1702329. doi: 10.1183/13993003.02329-2017. Print 2018 Feb.

Chen-Yuan Chiang^{1

2

3}, Arnaud Trébucq⁴, Alberto Piubello^{4

5}, Hans L Rieder^{6

7}, Armand Van Deun^{4

8}

¹ International Union Against Tuberculosis and Lung Disease, Paris, France cychiang@theunion.org.
² Division of Pulmonary Medicine, Dept of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
³ Division of Pulmonary Medicine, Dept of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
⁴ International Union Against Tuberculosis and Lung Disease, Paris, France.
⁵ Damien Foundation, Niamey, Niger.
⁶ Epidemiology, Biostatistics, and Prevention Institute, University of Zurich, Zurich, Switzerland.
⁷ Tuberculosis Consultant Services, Kirchlindach, Switzerland.
⁸ Mycobacteriology Unit, Institute of Tropical Medicine, Antwerp, Belgium.

No abstract available

Publication types